Application of Machine Learning Techniques to Assess Alpha-Fetoprotein at Diagnosis of Hepatocellular Carcinoma
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25041996 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Sergio Gil-Rojas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Department, Virgen de la Luz Hospital, 16002 Cuenca, Spain. Hauptthemen laut MEDLINE: alpha-Fetoproteins, Carcinoma, Hepatocellular, Liver Neoplasms, Machine Learning. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundación Investigación Hospital General Universitario de Valencia, University of Castilla-La Mancha (Spain).
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is the most common primary liver tumor and is associated with high mortality rates. Approximately 80% of cases occur in cirrhotic livers, posing a significant challenge for appropriate therapeutic management. Adequate screening programs in high-risk groups are essential for early-stage detection. The extent of extrahepatic tumor spread and hepatic functional reserve are recognized as two of the most influential prognostic factors. In this retrospective multicenter study, we utilized machine learning (ML) methods to analyze predictors of mortality at the time of diagnosis in a total of 208 patients. The eXtreme gradient boosting (XGB) method achieved the highest values in identifying key prognostic factors for HCC at diagnosis. The etiology of HCC was found to be the variable most strongly associated with a poorer prognosis. The widely used Barcelona Clinic Liver Cancer (BCLC) classification in our setting demonstrated superiority over the TNM classification. Although alpha-fetoprotein (AFP) remains the most commonly used biological marker, elevated levels did not correlate with reduced survival. Our findings suggest the need to explore new prognostic biomarkers for individualized management of these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastroenterology Department, Virgen de la Luz Hospital, 16002 Cuenca, Spain.
- Medical Analysis Expert Group, Institute of Technology, Universidad de Castilla-La Mancha, 16071 Cuenca, Spain.
- Medical Analysis Expert Group, Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), 45071 Toledo, Spain.
- Internal Medicine Unit, University Hospital of Guadalajara, 19002 Guadalajara, Spain.
- Department of Pharmacy, General University Hospital, 46014 Valencia, Spain.
- Faculty of Medicine, Universidad de Alcalá de Henares, 28801 Alcalá de Henares, Spain.
ORCID-Profile: Miguel Suárez, Pablo Martínez-Blanco, Natalia Martínez-García, Miguel Torralba
Förderung
- Fundación Investigación Hospital General Universitario de Valencia
- University of Castilla-La Mancha (Spain)
Zitieren
APA
Gil-Rojas, S., Suárez, M., Martínez-Blanco, P., Torres, A. M., Martínez-García, N., Blasco, P., Torralba, M., & Mateo, J. (2024). Application of Machine Learning Techniques to Assess Alpha-Fetoprotein at Diagnosis of Hepatocellular Carcinoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25041996
Vancouver
Gil-Rojas S, Suárez M, Martínez-Blanco P, Torres AM, Martínez-García N, Blasco P, et al. Application of Machine Learning Techniques to Assess Alpha-Fetoprotein at Diagnosis of Hepatocellular Carcinoma. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25041996
BibTeX
@article{GilRojas2024,
author = {Gil-Rojas, Sergio and Suárez, Miguel and Martínez-Blanco, Pablo and Torres, Ana M and Martínez-García, Natalia and Blasco, Pilar and Torralba, Miguel and Mateo, Jorge},
title = {Application of Machine Learning Techniques to Assess Alpha-Fetoprotein at Diagnosis of Hepatocellular Carcinoma},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25041996}
}
EUVIMED